IPO

JFL Life Sciences Limited IPO

NSE SME

Listed On: Sep 8, 2022 at ₹ 70.00

₹ 244000 /4000 Shares
*Min Investment

Check Allotment

25 Aug, 2022

Open Date

30 Aug, 2022

Close Date

06 Sep, 2022

Allotment Date

08 Sep, 2022

Listing Date
IPO Issue Details
  • Issue Price ₹61 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price 2,978,000 shares of ₹10(aggregating up to ₹18.17 Cr)
  • Listing at NSE SME
  • List Price 70.00
  • Listing Date 2022-09-08
  • Lead Manager GYR Capital Advisors Limited
  • Registrar KFin Technologies Limited
IPO Details
  • Retail Portion N/A
IPO Documents
DRHP
RHP
IPO Details


JFL Life Sciences Limited IPO is an SME IPO, priced at ₹61 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform.

The IPO bidding window is open from Aug 25, 2022 to Aug 30, 2022. The allotment is expected to be finalized on Sep 6, 2022, and the tentative listing date is Sep 8, 2022.


The registrar of the IPO is KFin Technologies Limited, and

Read More
IPO Subscription Analysis And Details
Retail
11.66x
Total
8.93x
As on QIB / NII Retail Total
Shares Offered / Reserved 1,414,000 1,414,000 2,828,000
Day 1 25-08-22 06:00 PM
0.24 x 0.75 x 0.49 x
Day 2 26-08-22 06:00 PM
0.51 x 1.65 x 1.08 x
Day 3 29-08-22 06:00 PM
0.66 x 3.71 x 2.19 x
Day 4 30-08-22 06:00 PM
6.19 x 11.66 x 8.93 x
Valuations
Earnings Per Share (EPS) ₹0.76/-
P/E Ratio N/A
RoNW 7.18%
Net Asset Value (NAV) - Post Issue ₹138.29/-
Company Financials
In Lakhs
In Lakh
31-Aug-19 31-Mar-20 31-Mar-21 28-Feb-22
Assets 1614.96 2432.59 2900.69 3662.86
Revenue 3177.96 3020.41 3286.89 2563.06
Profit After Tax 30.25 36.04 54.21 253.28
About Company

JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
The company's sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL's products are supplied to 10 developed and developing countries throughout the World.
JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.
JFL has two manufacturing units (on lease) in Gujarat.

Read More
- Promoter(s)

Smiral Ashwinkumar Patel

ejal Smiral Patel

Pre Issue Share Holding : 92.52%

Post Issue Share Holding : %

IPO - Issue Objectives
1

Repayment of secured and unsecured loans.

2

Funding the working capital requirements of the company.

3

General Corporate Purposes